What an LPAC Actually Does in a Private Equity Fund

What Is a Limited Partner Advisory Committee (LPAC) in Private Equity?

An LPAC is a governance body that gives a fund's largest limited partners direct influence over how a GP manages conflicts of interest, values portfolio assets, and handles transactions where the GP's interests and LP interests diverge. For anyone committing $10M+ to a single fund, understanding how the LPAC functions is not optional background knowledge. It is core due diligence.

The LPAC sits between the LP base and the GP, with authority defined in the limited partnership agreements that govern each fund. It does not run the fund. The GP retains operational control. But on the specific scenarios where conflicts are most acute, the LPAC's consent can be the difference between a GP acting unilaterally and being held accountable.

According to Preqin's Global Private Equity Report 2024, institutional LPs with commitments exceeding $50 million are most commonly invited to serve on LPACs, with mega-funds raising $5B or more typically forming committees of five to eight members drawn from their largest anchor investors. If you are writing checks at that scale, you will encounter LPAC participation as a question, not an abstraction.

LPAC Roles and Responsibilities in a PE Fund

The LPAC's authority is enumerated in the LPA, and no two funds are identical. That said, a consistent set of core responsibilities appears across most institutional funds.

Conflict-of-interest review. This is the LPAC's primary function. When the GP wants to pursue a transaction that creates a conflict, such as a cross-fund investment, a related-party deal, or a GP-led secondary, the LPAC reviews and either approves or rejects it. The ILPA Model LPA provides standardized language for these consent rights, including GP removal provisions, valuation dispute mechanisms, and key-person event procedures.

Valuation oversight. LPAC members review the GP's portfolio company valuations, particularly for illiquid assets marked under ASC 820 Level 3 fair value standards. In VC funds, where marks can materially affect management fee calculations and LP-reported NAV, this function carries direct financial consequences.

Key-person and GP removal events. If a named key person departs, the LPAC is typically consulted on whether to trigger a key-person event, which can suspend the investment period. In extreme cases, LPACs hold consent rights over GP removal.

Fund modifications. Extensions of the fund term, changes to the investment mandate, and amendments to fee structures generally require LPAC approval or at minimum formal consultation.

Reporting and audit review. LPAC members receive more detailed financial information than the broader LP base. The SEC's 2023 Private Fund Rules expanded mandatory disclosure requirements for GPs, including quarterly statements and annual audits, which directly increased the information flow available to LPACs. The Fifth Circuit vacated those rules in June 2024, but many GPs have maintained the enhanced disclosure practices voluntarily.

How an LPAC Resolves Conflicts of Interest Between GPs and LPs

The conflict-of-interest resolution function is where LPAC authority is most consequential and most contested.

GP-led secondaries illustrate this clearly. These are transactions where a GP moves assets from an older fund into a new continuation vehicle, effectively sitting on both sides of the deal as seller and buyer. According to Jefferies' Global Secondary Market Review, GP-led secondary transaction volume reached roughly $50 billion in 2023. Nearly all of these transactions require LPAC approval.

The structural conflict is obvious: the GP has an incentive to transfer assets at a valuation that benefits the new vehicle, potentially at the expense of existing LPs who must choose between rolling over or accepting a liquidity option at the offered price. The LPAC's job is to evaluate the fairness opinion, scrutinize the independent valuation, and assess whether the rollover economics are reasonable.

Research published through the Harvard Law School Forum on Corporate Governance documents that LPACs with clearly defined consent rights over GP conflicts of interest are associated with materially better LP outcomes in fund extension and valuation dispute scenarios. The mechanism is straightforward: a GP who knows the LPAC will scrutinize a transaction structures it more carefully from the outset.

Other common conflict triggers include:

• Allocation of co-investment opportunities between different funds managed by the same GP
• Transactions between portfolio companies across different GP-managed funds
• GP affiliate fee arrangements (consulting fees, monitoring fees paid by portfolio companies)
• Investments in companies where a GP principal holds a personal stake

The ILPA Principles 3.0, which have become the de facto industry standard for fund governance, outline specific procedures for how these conflicts should be disclosed, reviewed, and resolved. Funds that adopt ILPA-aligned governance give LPAC members clearer procedural authority. Funds that do not require more careful LPA negotiation before commitment.

LPAC Authority: Private Equity vs. Venture Capital Funds

The structural similarities between PE and VC LPACs obscure meaningful differences in how they operate day to day.

In PE funds, the LPAC tends to focus on structural governance: fee calculations, transaction approvals, and fund-level conflicts. In VC funds, valuation disputes are the most frequent trigger for LPAC engagement. Portfolio companies may carry marks that significantly affect management fee calculations in funds where fees are based on NAV rather than committed capital. LPAC members in VC funds are increasingly expected to engage independent valuation firms and apply ASC 820 fair value standards rigorously.

The investment committee decision-making processes at VC funds also differ from PE, with faster cycle times and less formalized deal documentation, which places more informal pressure on LPAC members to stay current on portfolio developments between formal meetings.

LPAC Seat Qualification Thresholds by Fund Size

Not every LP gets offered an LPAC seat. Qualification is primarily driven by commitment size, though strategic value, institutional credibility, and prior fund relationships also factor in.

These thresholds are not codified anywhere. They reflect market practice, and individual GPs deviate based on strategic LP relationships. A family office committing $15M to an emerging manager with a strong prior relationship may be offered an LPAC seat that a $30M institutional LP does not receive.

Compensation is almost universally absent. LPAC members serve without fees. The asymmetric benefit is informational, not financial.

How Ultra-HNW Investors Can Use LPAC Membership for Deal Sourcing and Co-Investment Access

This is the angle that most governance-focused discussions miss entirely.

LPAC membership rarely comes with a check. It consistently delivers asymmetric informational advantages. Members receive detailed portfolio company financials, GP pipeline updates, and early visibility into co-investment opportunities before they are offered to the broader LP base. For family offices and ultra-HNW individuals building concentrated private market portfolios, this information access is often the primary strategic rationale for seeking LPAC seats.

According to Pitchbook's US PE Breakdown 2023, co-investment rights negotiated at the fund formation stage, often through LPAC-level engagement, have become one of the most sought-after LP terms. Over 60% of institutional LPs cite co-invest access as a primary reason for anchor commitments.

The practical implication: if you are allocating $20M+ to a fund and the GP offers you an LPAC seat, the governance responsibility is real but secondary to the deal flow. You will see transactions before other LPs. You will have context on portfolio company performance that informs your co-investment decisions. And you will build a direct relationship with the GP team that creates optionality in future fund cycles.

Framing LPAC participation as a governance burden misses the point. It is deal-sourcing and due-diligence infrastructure, particularly valuable for investors running concentrated private market strategies across multiple GP relationships.

A few practical considerations for evaluating whether to accept a seat:

Time commitment. Expect two to four formal meetings per year plus ad hoc requests for conflict approvals. For active funds with frequent transactions, this can be materially more demanding.

Liability exposure. LPAC members are typically indemnified under the LPA, but the scope of indemnification varies. Review it before accepting. The ILPA Model LPA provides standardized indemnification language as a reference point.

Confidentiality obligations. LPAC members receive material non-public information about portfolio companies. This creates trading restrictions that extend beyond the fund itself. If you hold public market positions in sectors the fund invests in, discuss this with your legal counsel before accepting.

Conflicts within the LPAC. If you are on an LPAC alongside a competitor or a co-investor in the same portfolio companies, information-sharing dynamics become complicated. The LPA should address this; if it does not, negotiate side letters and customized investor agreements that protect your interests.

Key LPAC Consent Triggers: When Your Approval Actually Matters

Not all LPAC consultations carry equal weight. Some are informational. Others require formal consent that the GP cannot override.

The SEC's 2023 Private Fund Rules attempted to restrict GPs from seeking LPAC consent to override their own fiduciary duties, a provision that would have significantly curtailed a common GP practice. The Fifth Circuit vacated those rules in June 2024. The legal battle itself signals how central LPAC consent rights have become to the GP-LP power dynamic. Fund documents signed today may reflect either pre- or post-rule governance norms, making careful LPA review essential before committing capital.

Tax Implications of LPAC Participation and GP Compensation Structures

LPAC members do not receive compensation, so there is no direct tax event from serving. But LPAC decisions carry significant tax consequences for the LP base, and understanding those consequences is part of effective oversight.

Carried interest and IRC Section 1061. Under the Tax Cuts and Jobs Act, IRC Section 1061 extended the holding period for carried interest to qualify for long-term capital gains treatment to three years. When an LPAC evaluates a fund extension request or a GP-led secondary, the tax treatment of the GP's carry on the underlying assets is directly relevant. A GP seeking to extend a fund to avoid realizing carry at short-term rates has an economic incentive that may not align with LP interests. LPAC members should understand this dynamic when evaluating extension requests.

K-1 implications of valuation decisions. LPAC-approved valuations flow through to LP K-1s. In funds where management fees are calculated on NAV, aggressive marks increase the fee base and affect LP-reported performance. Challenging an inflated mark is not just a governance exercise. It has direct implications for the accuracy of your own net worth calculations and tax planning.

GP-led secondary tax treatment. When an LP rolls over into a continuation vehicle, the tax treatment depends on the transaction structure. A taxable exchange triggers gain recognition. A non-taxable rollover preserves basis. LPAC members evaluating these transactions should ensure the fairness opinion addresses tax consequences for rolling LPs, not just headline economics.

Estate planning considerations. For ultra-HNW individuals, LP interests in PE funds are illiquid assets with complex valuation profiles. LPAC-approved valuations at year-end affect gift and estate tax calculations for any fund interests transferred. If you are using GRATs or family limited partnerships to transfer PE fund interests, the LPAC's valuation decisions matter beyond your own portfolio.

Understanding private equity fee structures and aligning incentives across investment partnerships gives LPAC members the context to evaluate whether GP compensation structures are creating the conflicts they are reviewing.

The Legal Framework: LPAs, ILPA Standards, and LPAC Authority

The LPAC's authority derives entirely from the LPA. There is no statutory baseline. What the LPAC can and cannot do is whatever the fund's governing documents say it can and cannot do.

This makes limited partnership agreements the most important document to review before committing capital to any fund where you expect LPAC participation. Key provisions to examine:

• Consent vs. consultation. Does the LPAC formally approve conflicts, or does the GP merely consult the committee? The distinction is significant. Consultation without consent authority is largely ceremonial.
• Quorum and voting thresholds. What percentage of LPAC members must approve a conflict waiver? Unanimity provides maximum LP protection. Simple majority creates opportunities for GP influence over committee composition.
• Information rights. What financial data does the LPAC receive, and on what timeline? Quarterly financials received 30 days after quarter-end are less useful than monthly data with real-time portfolio updates.
• Indemnification scope. Are LPAC members indemnified for good-faith decisions? What conduct voids the indemnification? This matters more than most LPs realize when evaluating whether to accept a seat.
• GP removal procedures. Does the LPAC initiate the removal process, or does it require a separate LP vote? The ILPA Model LPA provides standardized language here that represents best practice.

The ILPA Principles 3.0 outline best practices for LPAC composition, authority, and conflict-of-interest resolution that have become the de facto industry standard. Funds that align with ILPA principles give LPAC members clearer procedural authority and stronger governance infrastructure. Funds that deviate require more careful negotiation before commitment.

Understanding LP-GP dynamics and fund structure gives LPAC members the structural context to evaluate whether a specific fund's governance documents reflect market-standard protections or GP-favorable carve-outs.

LPAC Governance Across Fund Sizes: What Changes at Scale

The LPAC's practical function differs meaningfully between a $500M emerging manager fund and a $15B mega-fund. Scale affects everything from meeting cadence to the sophistication of conflict scenarios.

At mega-funds, LPAC members are typically large institutional investors, sovereign wealth funds, pension systems, and endowments with dedicated PE teams. They bring professional staff to LPAC work. They negotiate governance terms aggressively at fund formation. They have the resources to engage independent counsel when evaluating complex conflict scenarios.

At mid-market and emerging manager funds, LPAC members are more likely to include family offices and ultra-HNW individuals. The governance infrastructure is less formalized. The GP may be less experienced with LPAC process. This creates both more risk and more influence: a sophisticated LPAC member at a smaller fund can shape governance norms in ways that are simply not possible at a mega-fund where the committee is one of many institutional checks.

The chief investment officer responsibilities at smaller funds often overlap with LPAC engagement in ways that do not occur at larger institutions with dedicated investor relations teams. This informality can be an advantage for LPAC members who want substantive access to the GP's thinking, or a risk if it means governance processes are not consistently followed.

For ultra-HNW individuals evaluating LPAC participation at emerging managers, the governance risk is real. A GP with limited institutional LP experience may not have robust conflict-of-interest procedures. The LPAC member may be the primary check on GP behavior. That is a meaningful responsibility that requires time, expertise, and willingness to act when necessary.

How LPAC Decisions Affect Portfolio Companies and Fund Outcomes

LPAC decisions do not stay contained within the fund structure. They affect how private equity acquisitions impact portfolio companies and ultimately determine whether the fund's governance infrastructure supports or undermines value creation.

When an LPAC approves a GP-led secondary, it sets the price at which existing LPs exit or roll over. That price affects the portfolio company's implied valuation going forward, its ability to raise additional capital, and the GP's incentive structure in the continuation vehicle.

When an LPAC challenges an aggressive valuation mark, it creates accountability that flows through to management fee calculations, LP reporting, and the GP's track record. A GP who knows marks will be scrutinized has less incentive to inflate them.

When an LPAC fails to exercise its authority, the consequences can be severe. Weak LPAC governance has been a contributing factor in several high-profile fund governance failures where GPs pursued self-interested transactions without adequate LP oversight. The private equity audit requirements that apply to registered investment advisers provide a parallel accountability mechanism, but they do not substitute for active LPAC oversight.

The Harvard Law School Forum on Corporate Governance research is direct on this point: LPACs with clearly defined consent rights are associated with materially better LP outcomes. The mechanism is not complicated. Accountability structures work when they are actually enforced.

The Regulatory Environment Around LPAC Authority

The regulatory context for LPAC governance is actively contested, and fund documents signed in the past two years may reflect very different assumptions about GP obligations.

The SEC's August 2023 Private Fund Rules represented the most significant attempt to regulate GP-LP dynamics in decades. Among other provisions, the rules would have restricted GPs from seeking LPAC consent to override their own fiduciary duties, a practice that had become common in fund documents as a way to pre-approve potential conflicts. The Fifth Circuit vacated the rules in June 2024, ruling that the SEC exceeded its statutory authority.

The practical effect for LPs: the legal battle revealed how central LPAC consent rights have become to the GP-LP power dynamic, and how much GPs value the ability to use LPAC approval as a fiduciary shield. Even with the rules vacated, many GPs have voluntarily maintained the enhanced disclosure practices the rules would have required, partly because institutional LPs have made clear they expect them.

For anyone reviewing fund documents today, the key question is whether the LPAC's consent rights are structured as genuine LP protections or as a mechanism for the GP to obtain pre-approval for conflicts that should not be approved at all. The distinction between GPs and LPs in terms of fiduciary obligations is fundamental here: the GP owes duties to the fund; the LPAC represents the LP interest in enforcing those duties.

Regulatory scrutiny of private markets is not diminishing. The SEC's focus on private fund governance, even after the rule vacatur, signals continued attention to LPAC authority, GP disclosure obligations, and the adequacy of LP protections in fund documents.

References

• Institutional Limited Partners Association (ILPA) -- "ILPA Principles 3.0: Fostering Transparency, Governance, and Alignment of Interests for General and Limited Partners" (2019)
• Institutional Limited Partners Association (ILPA) -- "ILPA Model Limited Partnership Agreement" (2020)
• U.S. Securities and Exchange Commission -- "Private Fund Advisers; Documentation of Registered Investment Adviser Compliance Reviews (Final Rule)" (2023)
• Preqin -- "Global Private Equity Report 2024" (2024)
• Internal Revenue Service -- "IRC Section 1061 -- Carried Interests"
• Harvard Law School Forum on Corporate Governance -- "Private Equity Fund Governance: The Role of Limited Partner Advisory Committees" (2022)
• Pitchbook -- "US PE Breakdown: Annual Report 2023" (2024)
• Debevoise & Plimpton LLP -- "Private Equity Funds: Key Business, Legal and Tax Issues" (2023)
• Jefferies -- "Global Secondary Market Review" (2024)